Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies.
Vergote I, Pujade-Lauraine E, Pignata S, Kristensen GB, Ledermann J, Casado A, Sehouli J, Mirza M, Fossati R, Marth C, Creutzberg C, Del Campo J, Siddiqui N, Calvert P, Bamias A, Tulunay G, van der Zee AG, du Bois A; European Network of Gynaecological Oncological Trial Groups. Vergote I, et al. Among authors: van der zee ag. Int J Gynecol Cancer. 2010 Apr;20(3):476-8. doi: 10.1111/IGC.0b013e3181d3caa8. Int J Gynecol Cancer. 2010. PMID: 20375816 No abstract available.
European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Industry Partners--First Update 2015.
du Bois A, Reuss A, Pujade-Lauraine E, Pignata S, Ledermann J, Casado A, Sehouli J, Mirza M, Colombo N, Marth C, Witteveen E, Del Campo J, Calvert P, Aravantinos G, Vardar MA, van der Zee AG, Korach J, Taskiran C, Fehr M, Glasspool R, Pfisterer J, Cibula D, Vergote I; member trial groups of the European Network of Gynaecological Oncological Trial Groups (ENGOT). du Bois A, et al. Among authors: van der zee ag. Int J Gynecol Cancer. 2015 Sep;25(7):1328-30. doi: 10.1097/IGC.0000000000000478. Int J Gynecol Cancer. 2015. PMID: 26067859
European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer.
Oonk MHM, Planchamp F, Baldwin P, Bidzinski M, Brännström M, Landoni F, Mahner S, Mahantshetty U, Mirza M, Petersen C, Querleu D, Regauer S, Rob L, Rouzier R, Ulrikh E, van der Velden J, Vergote I, Woelber L, van der Zee AGJ. Oonk MHM, et al. Int J Gynecol Cancer. 2017 May;27(4):832-837. doi: 10.1097/IGC.0000000000000975. Int J Gynecol Cancer. 2017. PMID: 28441255
Training in bowel and upper abdominal surgery in gynaecological oncology: European Society of Gynecological Oncology (ESGO) Statement.
Cibula D, Verheijen R, Lopes A, Amant F, Beller U, Colombo N, Gitsch G, Kesic V, Kimmig R, Markowska J, Marth C, Reed N, Rodolakis A, Salvesen H, Vaitkiene D, van der Zee AG, Zola P. Cibula D, et al. Among authors: van der zee ag. Int J Gynecol Cancer. 2011 Oct;21(7):1264-5. doi: 10.1097/IGC.0b013e3182208141. Int J Gynecol Cancer. 2011. PMID: 21720255 No abstract available.
ESGO statement on cervical cancer vaccination.
Vergote I, van der Zee AG, Kesic V, Sert B, Robova H, Rob L, Reed N, Luesley DM, Leblanc E, Hagen B, Gitsch G, du Bois A, di Vagno G, Colombo N, Beller U, Ayhan A, Jacobs I. Vergote I, et al. Among authors: van der zee ag. Int J Gynecol Cancer. 2007 Nov-Dec;17(6):1183-5. doi: 10.1111/j.1525-1438.2007.01129.x. Int J Gynecol Cancer. 2007. PMID: 17997794 No abstract available.
ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer.
van der Zee AG, Colombo N, Gitsch G, Reed N, Amant F, Cibula D, Kesic VI, Kimmig R, Lopes AD, Markowska J, Marth C, Radolakis A, Salvesen H, Vaitkiene D, Verheijen RH, Zola P. van der Zee AG, et al. Int J Gynecol Cancer. 2012 Jan;22(1):175. doi: 10.1097/IGC.0b013e3182261f15. Int J Gynecol Cancer. 2012. PMID: 22193647 No abstract available.
Sentinel node dissection is safe in the treatment of early-stage vulvar cancer.
Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, Maggioni A, Gaarenstroom KN, Baldwin PJ, Van Dorst EB, Van der Velden J, Hermans RH, van der Putten H, Drouin P, Schneider A, Sluiter WJ. Van der Zee AG, et al. Among authors: van dorst eb, van der velden j, van der putten h. J Clin Oncol. 2008 Feb 20;26(6):884-9. doi: 10.1200/JCO.2007.14.0566. J Clin Oncol. 2008. PMID: 18281661 Free article. Clinical Trial.
Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma.
Diamandis EP, Scorilas A, Fracchioli S, Van Gramberen M, De Bruijn H, Henrik A, Soosaipillai A, Grass L, Yousef GM, Stenman UH, Massobrio M, Van Der Zee AG, Vergote I, Katsaros D. Diamandis EP, et al. Among authors: van gramberen m, van der zee ag. J Clin Oncol. 2003 Mar 15;21(6):1035-43. doi: 10.1200/JCO.2003.02.022. J Clin Oncol. 2003. PMID: 12637468
Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer.
Tomar T, Alkema NG, Schreuder L, Meersma GJ, de Meyer T, van Criekinge W, Klip HG, Fiegl H, van Nieuwenhuysen E, Vergote I, Widschwendter M, Schuuring E, van der Zee AGJ, de Jong S, Wisman GBA. Tomar T, et al. BMC Med. 2017 Jun 23;15(1):116. doi: 10.1186/s12916-017-0870-0. BMC Med. 2017. PMID: 28641578 Free PMC article.
297 results